Home
/ Eutilex
/ Competitors

Eutilex Competitors and Similar CompaniesClear all

Eutilex's competitors and similar companies include Zymeworks, JW Therapeutics and ImmPACT-Bio.

	Eutilex Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.	Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.	JW Therapeutics JW Therapeutics is a biotech company focusing on clinical cell therapy technology.	ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
Founding Date	Founding Date 2015	Founding Date 2003	Founding Date 2016	Founding Date 2017
Type	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy
Locations	Locations KR HQ	Locations Vancouver, CA HQ Seattle, US	Locations CN HQ Suzhou Shi, CN	Locations Camarillo, US HQ Rishon Le Tsiyon, IL
Employees	Employees 141	Employees 45519% increase	Employees 106	Employees 845% decrease
Financial
Revenue (est.)	Revenue (est.) ₩9.5b (FY, 2024)	Revenue (est.) $106m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income (₩29.5b) (FY, 2024)	Net income ($81.1m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 90m (about 8 years ago)	Latest funding round $ 18m (almost 6 years ago)
Total funding raised	Total funding raised $ 18.9m	Total funding raised $ 125.9m	Total funding raised $ 90m	Total funding raised $ 18m